MacroGenics Files 8-K: Material Agreement, Other Events
Ticker: MGNX · Form: 8-K · Filed: Jun 10, 2025 · CIK: 1125345
Sentiment: neutral
Topics: material-agreement, 8-k
Related Tickers: MGNX
TL;DR
MGNX filed an 8-K for a material agreement - check for details.
AI Summary
On June 9, 2025, MacroGenics, Inc. filed an 8-K report detailing a material definitive agreement. The filing also includes other events and financial statements/exhibits. The company is incorporated in Delaware and its principal executive offices are located at 9704 Medical Center Drive, Rockville, Maryland.
Why It Matters
This 8-K filing indicates a significant new agreement for MacroGenics, Inc., which could impact its business operations and financial standing.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities that may affect the company's future performance.
Key Players & Entities
- MACROGENICS, INC. (company) — Registrant
- June 9, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 9704 Medical Center Drive, Rockville, Maryland 20850 (address) — Address of Principal Executive Offices
- 301-251-5172 (phone_number) — Registrant's telephone number
FAQ
What is the nature of the material definitive agreement filed by MacroGenics, Inc.?
The 8-K filing indicates the entry into a material definitive agreement, but the specific details of the agreement are not provided in the provided text excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 9, 2025.
Where are MacroGenics, Inc.'s principal executive offices located?
MacroGenics, Inc.'s principal executive offices are located at 9704 Medical Center Drive, Rockville, Maryland 20850.
What is the company's state of incorporation?
The company is incorporated in Delaware.
What is the trading symbol for MacroGenics, Inc. common stock?
The provided excerpt mentions that common stock is registered pursuant to Section 12(b) of the Act, but the trading symbol is not explicitly stated in this portion of the filing.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 10, 2025 regarding MACROGENICS INC (MGNX).